Fore Biotherapeutics Company

We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Technology: Small Molecules
Industry: Geroscience
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 2011-01-01
Employees Number: 11-50
Investors Number: 12
Total Funding: 91500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-09-15
Last Funding Type: Series C

Visit Website
yaron@fore.bio
http://fore.bio
Register and Claim Ownership